Urologic Oncology: Seminars and Original Investigations
Volume 25, Issue 3 , Pages 196-200, May 2007

Does a delay in initiating definitive therapy affect biochemical recurrence rates in men with clinically localized prostate cancer?

  • Joseph J. Phillips, M.D.

      Affiliations

    • Department of Urology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA
    • ,
  • M. Craig Hall, M.D.

      Affiliations

    • Piedmont Urological Associates, High Point, NC 27262, USA
    • ,
  • W. Robert Lee, M.D., M.S., M.A.Ed.

      Affiliations

    • Department of Radiation Oncology, Duke University School of Medicine, Durham, NC 27710, USA
    • ,
  • Peter E. Clark, M.D.

      Affiliations

    • Department of Urology, Vanderbilt University Medical Center, Nashville, TN 37232-2765, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-615-322-3807; fax: +1-615-322-8990.

Received 28 February 2006; received in revised form 5 June 2006; accepted 6 June 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1078-1439(06)00151-7

doi:10.1016/j.urolonc.2006.06.004

Urologic Oncology: Seminars and Original Investigations
Volume 25, Issue 3 , Pages 196-200, May 2007

Article Tools

* Image Usage & Resolution